drugset / Trial / NCT00762957
Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of TAK-559, once daily (QD), taken in combination with metformin in treating subjects with type 2 diabetes mellitus
Timeline
- Start
- 2004-11
- Primary completion
- 2004-12
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IMIGLITAZAR | Small molecule | 16 mg | Oral |
| Subject | IMIGLITAZAR | Small molecule | 32 mg | Oral |
| Comparator | Metformin | Small molecule | — | Oral |